好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Assess the Efficacy and Safety of Lacosamide in Subjects with Painful Distal Diabetic Neuropathy
Headache and Pain
(-)
001
Authors/Disclosures
James P. Wymer, MD, PhD, FAAN (Department of Neurology, University of Florida) No disclosure on file
No disclosure on file
Rashi K. Krishnan, MD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Jason Chang, MD (MedStar Washington Hospital Center) Dr. Chang has nothing to disclose.
No disclosure on file
Ariel Luzzi No disclosure on file
No disclosure on file
Khalid Al Sherbini, MD (University Clinical Health - UTHSC) Dr. Al Sherbini has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ceribell . Dr. Al Sherbini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Andrei V. Alexandrov, MD (Department of Neurology, UTHSC) The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.